Natural Killer Cells Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Natural Killer Cells Therapeutics Market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2027, registering a CAGR of 17% from 2021 to 2027. 

Natural killer (NK) cell therapeutics target multiple pathogenic antigens with efficient cytotoxicity and reduce the risk of cytokine storms. It can be produced from a variety of sources without relying on patient-specific immune cells. Currently, several strategies have been developed, such as ex vivo preregulation with cytokines or small molecule drugs, and chimeric antigen receptor (CAR) NK manipulation to improve the efficacy of NK cell therapeutics. Researchers also focus on maximizing the therapeutic effect of allogeneic NK cells through robust expansion, enhanced targeting, and extended persistence of potent immune cells. It may also help trigger a strong and persistent anticancer immune-mediated attack.

Market Segments

By Type

• Natural Killer (NK) Cell Therapies
• Natural Killer (NK) Cell Directed Antibodies

By Application

• Gastrointestinal Diseases
• Immune-proliferative Disorders
• Cancer
• Others

Key Players

• Affimed
• Celgene Corporation
• Glycostem
• Nkarta Therapeutics
• Innate Pharma S.A
• Ziopharm Oncology, Inc.
• NantKwest
• NKT Therapeutics Inc.
• Fate Therapeutics
• Fortress Biotech Inc.

Scope of the Report

The research study analyzes the global Natural Killer Cells Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Natural Killer Cells Therapeutics Market Report

1. What was the Natural Killer Cells Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Natural Killer Cells Therapeutics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Natural Killer Cells Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.